NANDITA PUCHAKAYALA: Open Payments
NPI 1720320989 · CHINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$49,202 in 152 payments from 14 companies in 2025. Trend: 2023 $10,326 · 2024 $15,905 · 2025 $49,202
Honoraria: $17,325Consulting: $13,625Speaker / faculty: $13,460Food & beverage: $3,698Travel & lodging: $993Education: $101
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 28 | $18,998 |
| Janssen Scientific Affairs, LLC | 1 | $13,625 |
| Teva Pharmaceuticals USA, Inc. | 25 | $9,507 |
| ABBVIE INC. | 25 | $4,916 |
| Janssen Pharmaceuticals, Inc | 23 | $804 |
| Neurocrine BioSciences, Inc. | 14 | $633 |
| Otsuka America Pharmaceutical, Inc. | 11 | $248 |
| E.R. Squibb & Sons, L.L.C. | 10 | $161 |
| Lundbeck LLC | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
Products named: Auvelity, SPRAVATO, UZEDY, VRAYLAR, INGREZZA, REXULTI, AUSTEDO XR, COBENFY.
Industry payments across CA — which companies pay providers there.
